Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership

Image for article Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
News Source : Yahoo Entertainment

News Summary

  • Twist Bioscience Corporation (NASDAQ: TWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)-driven drug discovery ecosystem.
  • On September 16, the company confirmed a strategic partnership with Lilly TuneLab, a platform created by Eli Lilly and Company (NYSE: LLY).
  • As part of the strategic partnership, Twist will provide antibody characterization data services for TuneLab.
  • The partnership could also create a potential avenue for incremental service revenue.
  • However, the near-term financial impact is unclear as the partnership does not include disclosed revenue commitments.
Twist Bioscience Corporation (NASDAQTWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)driven drug discovery ecosystem.

Must read Articles